Dr. Paul Sax offers both a personal and professional take on the study, in his blog
HIV and ID Observations.
New research — as well as new CDC guidelines — indicates that individuals with latent tuberculosis (TB) can now take a 3-month course of combination therapy (isoniazid plus rifapentine) to prevent active TB, instead of the standard 9-month isoniazid regimen. Dr. Paul Sax explains the relevance on a personal level, in his blog HIV and ID Observations.